PolyPid Ltd. (PYPD:NASDAQ) closed at $6.60 on November 11, 2026, up 4.60% on the day. The stock trades 7.6% below its 52-week high of $7.14 and 88.6% above its 52-week low of $3.50. Over the past year, it gained 76.0%. PolyPid Ltd. is part of the Miscellaneous sector.
In 252 trading sessions since November 11, 2025, PYPD closed higher on 126 days (50%). Its best day was July 6, 2026 (+11.16%) and its worst was July 21, 2026 (-27.38%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 2 times.
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.
Find more stocks like PYPD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.